The World Health Organization listed the Moderna COVID-19 vaccine for emergency use late Friday — a step that will allow countries to speed up their own regulatory approval.
The Geneva-based body said the emergency-use listing is also a prerequisite for the vaccine to be part of the COVAX facility which aims to share vaccines fairly around the world.
Moderna’s becomes the fifth vaccine to be approved for emergency use by the WHO — following those of Pfizer/BioNTech, Johnson & Johnson and two versions of the Oxford/AstraZeneca vaccine. It has already received a green light from EU and U.S. regulators.
The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) reviewed the vaccine in January and recommended its use in adults 18 and above. The group found it had an efficacy rate of 94.1 percent.
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
- ‘No other way to spin it’: CNN expert says inflation number ‘positive news’ - December 18, 2025
- Fairfax County freed illegal despite ICE request — now a man is dead - December 18, 2025
- US may be entering moderate moment as voters reject radicalism, poll suggests - December 18, 2025
Comment
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.
BPR INSIDER COMMENTS
Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!
